TPG
VC Fund
San Francisco, United States
TPG is a VC fund in San Francisco focused on Health Care and Software. TPG offers a diverse range of services, including asset management, telecommunications, and cultural exchange programs. The firm manages investments across various sectors, focusing on innovative strategies to optimize returns. In telecommunications, TPG provides internet and mobile plans tailored to consumer needs, ensuring connectivity for users.Additionally, TPG facilitates cultural exchange by connecting certified English-speaking teachers with educational institutions, promoting cultural diversity in classrooms. This multifaceted approach allows TPG to address the needs of different markets while supporting both economic growth and social development.
- Total investments:
- 247
- Last investment:
- Lead investor:
- 53%
- Fund size:
- $46M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries TPG invests in
Stages TPG invests in
Countries TPG invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 44 contacts → | |||
Round size
- Series B
- $12M–$160M
- Series C
- $10M–$380M
- Private Equity
- $60M–$1B
Investment Focus
Industry
- Health Care 31 (13%)
- Software 29 (12%)
- Financial Services 26 (11%)
- Information Technology 24 (10%)
- Biotechnology 23 (9%)
Stage
- Private Equity 68 (28%)
- Series C 30 (12%)
- Series B 21 (9%)
- Post-IPO Equity 18 (7%)
- Venture - Series Unknown 14 (6%)
Country
- United States 123 (50%)
- India 13 (5%)
- China 10 (4%)
- Australia 4 (2%)
- South Korea 4 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Akash Pradhan
Vice President
|
Vice President | Total investments: 1 | Find email | |
Arun Agarwal
Managing Director
|
Managing Director | Total investments: 6 | Find email | |
Carolyn Ng
Partner and Managing Director
|
Partner and Managing Director | Total investments: 8 | Find email | |
Chang Sun
Managing Partner
|
Managing Partner | Total investments: 3 | Find email | |
Edward Beckley
Partner
|
Partner | Total investments: 6 | Find email | |
| See all 44 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families. | $123M / Series C / Sep 16, 2026 | ||
| Crusoe is on a mission to help the oil industry reduce routine flaring of natural gas. They are passionate about creating solutions that benefit the environment, local communities, and energy producers.Crusoe Energy Systems provides oil and gas companies with a fast, low cost and simple solution to natural gas flaring. As the energy industrystruggles with pipeline constraints and increasing regulations around flaring and combusting, Crusoe is here to help. Their service lets operators preserve or regain regulatory compliance, maintain existing production and facilitate future development. | $3.9B / Series F / Sep 03, 2026 | ||
| Databricks is a software platform that helps its customers unify their analytics across the business, data science, and data engineering. It also provides a Unified Analytics Platform for data science teams to collaborate with data engineering and lines of business to build data products. The company was founded in 2013 and is headquartered inSan Francisco, California. | $5B / Private Equity / Aug 13, 2026 | ||
| Super.com is the savings super app for everyday Americans. The app helps customers save across travel, entertainment, financial services, and daily spending. The Super+ membership supercharges the app. Members get 10% cashback on hotels, unlock financial tools like cash advances and credit building, and much more. Since 2016, Super.com hasdelivered more than $1 billion in savings. Learn more at Super.com | $65M / Series D / Jul 07, 2026 | ||
| Harvest Capital Real Estate Services is a residential real estate agency that offers real estate investment and asset management services. | $10.9M / Debt Financing / May 15, 2026 | ||
| Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. | $25M / Post-IPO Equity / May 08, 2026 | ||
| OpenAI Deployment Company provides artificial intelligence software services. The Deployment Company is a JV formed by OpenAI in partnership with TPG Inc (NASDAQ:TPG), Brookfield Asset Management Inc (NYSE:BAM), Advent, and Bain Capital Specialty Finance Inc (NYSE:BCSF). | $4B / Private Equity / May 04, 2026 | ||
| Aster is the new name spearheading a vital vertical of DM Healthcare. It is a corollary of expansion integrating the current brands of clinics, polyclinics, pharmacies and diagnostic centres at 95 locations under one name. Aster interfaces with existing and new customers through Aster Hospital, Aster Medical Centre, Aster Pharmacy and AsterDiagnostic Centre. | Post-IPO Equity / Apr 30, 2026 | ||
| Zūm is a provider of safe, efficient, and reliable child transportation for school districts and busy families. Zūm saves schools money and parents time by providing flexible transportation options through its network of highly vetted drivers and advanced scheduling, routing, and tracking technology.The company currently provide children’stransportation service in the San Francisco Bay Area, all of Los Angeles, Orange County, and San Diego.Zūm was founded in 2015 and is based in Redwood City, California. | $100M / Private Equity / Apr 16, 2026 | ||
| ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment. | $75M / Series C / Apr 14, 2026 | ||
| See all 247 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TPG invest in?
TPG invests primarily in Health Care, Software and Financial Services startups, most often at Private Equity and Series C stage. Most of the 247 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TPG's check size?
TPG typically joins rounds of $12M–$160M at Series B, $10M–$380M at Series C and $60M–$1B at Private Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TPG participates in.
How do I contact TPG?
Public channels for TPG include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TPG?
The team at TPG includes Akash Pradhan (Vice President), Arun Agarwal (Managing Director) and Carolyn Ng (Partner and Managing Director), among 44 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
